TopBuild Corp.

▲ Bull Case

• ◆QXO deal closes at $505/share in Q3 2026 with board-approved status, confirmed financing, and minimal antitrust risk; investors collect +$92/share (+22%) gross return within ~6 months at ~82–85% deal probability.
• ◆SPI/Progressive integrations deliver $35–45M combined synergies by FY2027–2028, driving EBITDA recovery to $1.2–1.3B, enabling re-rating to 16–18x EV/EBITDA ($500–590/share standalone); DI precedent (2021) shows margin expansion from 15.9% to 19.5% in two years post-integration.
• ◆U.S. housing starts recovery from 1.0M to 1.4–1.5M SF units (plausible with 1–2 Fed rate cuts) plus IRA energy code uplift (IECC 2021 requires 15–30% more insulation) drives $500–700M organic revenue and $90–120M EBITDA upside not yet in consensus models.

▼ Bear Case

• ◆QXO deal breaks due to regulatory review, financing constraints, or changed circumstances; stock reprices to $300–350 pre-deal range, representing 20–32% loss from $413; standalone investment case must hold without deal backstop.
• ◆SPI integration costs exceed budget, housing starts remain flat at 1.0M through 2026–27, leverage stays elevated above 3.0x ND/EBITDA; simultaneous integration of two distinct platform businesses (industrial distribution + roofing installation) exceeds management bandwidth; FY2026 EBITDA misses guidance floor <$950M.
• ◆IBP closes scale gap through transformative acquisition (>$1B), eroding BLD's 8–12% purchasing cost advantage; margin differential (BLD 14.6% vs. IBP ~13%) compresses, eliminating multiple premium rationale.

“Analyst community (12 Buy, avg. target $475) is bifurcated: deal-certainty camp views $505 as near-certain and focuses on arb execution; standalone compounder camp argues $505 may undervalue BLD's long-term potential ($600–700/share by 2030 if management's $9–10B revenue vision materializes). Primary debate is whether $505 is the right price and what happens post-close with QXO's consolidated platform, not whether deal closes.”

• ◆QXO shareholder approval + regulatory clearance (Q3 2026): +$92/share to $505 if achieved; 82–85% probability
• ◆Q2 2026 earnings (August): EBITDA trajectory confirming $270M+ quarterly run-rate (≥17.8% margin); validates integration on track; ~55% probability of achieving
• ◆Federal Reserve rate cuts (H2 2026): 1–2 additional cuts drive housing starts inflection above 1.1M SF, reducing BLD floating-rate interest burden; ~65% probability
• ◆SPI synergy announcement (Q2–Q3 2026): Confirmation of $30–40M run-rate synergy by FY2027 reduces integration uncertainty discount; ~60% probability
• ◆Residential housing starts inflection (Q3–Q4 2026): SF starts ≥1.1M annualized signals organic growth re-acceleration; ~50% probability by Q1 2027

• ◆QXO deal breaks (15–18% probability): regulatory delay, financing constraints, or changed circumstances; stock reprices to $300–350 pre-deal range; high severity; Q3 2026 timing
• ◆Housing starts remain depressed (25% probability): SF stays ≤1.0M through 2026–27; eliminates organic growth catalysts; medium-high severity; 12–18 month horizon
• ◆SPI integration cost overruns (30% probability): synergies delayed 18+ months or fail; margin recovery timeline extended; management bandwidth stretched; medium severity; 12–24 months
• ◆Interest rates elevated (25% probability): floating-rate debt burden grows; financial flexibility constrained; credit market stress in 2028–2029 refinance window; medium severity; 6–12 months
• ◆IBP competitive response (20% probability): transformative acquisition closes scale gap; moat narrowing; medium severity; 24–36 month horizon
• ◆Goodwill impairment (10% probability): SPI fails to perform, triggers >$400M write-down; non-cash but signals management credibility break; medium-low severity; 18–36 months